Go back

How To Reverse Or Reduce Your Risk Of Alzheimer’s And Dementia

62m 19s

How To Reverse Or Reduce Your Risk Of Alzheimer’s And Dementia

This transcription from "The Doctor's Pharmacy" podcast emphasizes that neurodegenerative diseases like Alzheimer's have a long pre-symptomatic phase, making early intervention critical. The discussion highlights that lifestyle factors are powerful tools for brain health. Research, such as the FINGER study, demonstrates that multimodal interventions involving diet, exercise, and managing health conditions can not only prevent cognitive decline but also reverse it in older adults. A central theme is that chronic inflammation, fueled by poor diet, lack of exercise, and even gum disease, is a primary pathway for brain disease. While genetics like the APOE-4 gene increase risk, they are not deterministic; proactive lifestyle changes can alter genetic expression and outcomes. The conversation underscores a paradigm shift: the brain is intimately connected to overall bodily health, particularly through the gut microbiome and systemic inflammation, moving beyond the outdated view of it as an isolated organ. The episode advocates for a functional medicine approach focused on creating health rather than just treating disease.

Transcription

11508 Words, 64254 Characters

English
Coming up on this episode of the doctor's pharmacy is the pre-symptomatic and then there's the symptomatic I think that ketogenic diets make more sense in the symptomatic Base of the disease. It's been used to treat other brain disease for a long long time Hey everyone it's Dr. Mark People are always surprised when I tell them that even with a Whole Foods diet rich in plants We can still be nutrient deficient and addressing nutrient deficiencies is one of the lowest hanging fruits for optimizing our health and feeling better Any age and that is why I'm a huge fan of AG one from athletic greens since our soils are so damaged The plants can't extract the nutrients because there's no living matter anymore and We're up against issues like chronic stress and toxicity and sleep deprivation like never before and our bodies need some extra help getting All the right information to work properly now that information comes in the form of vitamins and minerals and phytonutrients and good bacteria All of which help our cell remember how to efficiently tackle their important jobs So one of the things that is every day to support my diet is AG one from athletic greens with just one scoop of AG one I get 75 high quality vitamins minerals whole foods source superfoods probiotics adapt to genes and more to support my entire body Even with a really healthy diet It's hard to hit the mark for all our nutrient needs so I feel better knowing I have some extra help from AG one Unlike other supplements and powders out there AG one is third party tested and made without GMO nasty chemicals are artificial anything actually It tastes great kind of like a tropical green drink I like it on its own mixed with water, but it also works really well in most smoothies If you're curious about trying AG one from athletic greens for yourself right now They're offering my community 10 free travel plaques with your first purchase all you have to do is visit athletic greens.com forward slash hymen again. That's athletic greens.com forward slash hymen to take ownership over your health and pick up the ultimate daily Nutritional insurance now one of today's episode sponsors is butcher box I love this company because they make eating high quality meat and seafood accessible Affordable and most importantly really delicious when I talk about high quality animal protein That means caring for the lives of the animals and the livelihoods of the farmers Reducing our impact on the environment and the climate and feeding our bodies real food to promote optimal health This is a huge caveat when it comes to eating meat and seafood. It has to be clean to be a good part of your diet But your box delivers a hundred percent grass fed grass finish beef and wild caught salmon right to my door They have different package and frequency options available so you can order the best combination for you and your family Without any penalty if you decide to cancel and shipping is always free the meat and seafood I get from butcher box is way better than what I find in the grocery store For a quick weeknight meal this time of year I love grilling up some of their wild caught salmon and throwing it together with some arugula red onion lots of basil Balsamic vinegar alongside some spaghetti squash yum When you sign up to butcher box today You'll get two pounds of wild caught alaskan salmon free in your first box by going to butcher box calm Slash pharmacy that's two pounds of sustainably caught wild alaskan salmon free by going to butcher box calm For exercise pharmacy that's F-A-R-M-A-C-Y. I hope you take advantage of this great offer I know you can love butcher box as much as I do now. Let's get back to this week's episode of the doctor's pharmacy Hi, this is Lauren Fien one of the producers of the doctor's pharmacy podcast Millions of Americans are affected by neurodegenerative diseases like Alzheimer's dementia, ALS and more The good news is that there are many simple steps we can take every single day to protect our brains and reduce the risk for or even Reverse symptoms of cognitive decline in today's episode we feature three conversations from the doctor's pharmacy about why it is so important to take care of our brains when we are young And what to do if we are experiencing a brain condition Dr. Hyman speaks with Dr. Marwan Sabah about the role of the APOE for gene With Dr. Richard Isaacson on lifestyle modifications that can prevent Alzheimer's and even reverse its decline With Dr. Richard Isaacson on lifestyle modifications that can prevent and even reverse Alzheimer's And with Dr. Jay Lombard about bacteria is the cause of neurodegenerative disease Let's jump in By the time somebody walks into my office with memory loss they've had disease changes in their brains for two decades And we understand that biologically now so you're seeing now a whole And you can see that on imaging scan we can see that on whole and imaging scan so we're now seeing now a big push to move The calculus beyond the time of symptoms to much earlier and try to find people and identify people at risk Along the way so but most of that research has been focused on drug interventions to prevent the Or prevent delay or a for stall the onset of symptoms But along the way of course if I'm going to I'm flaminate in my 70s and I know my disease started in my 50s or 40s we can change Beyond drugs we can change to say lifestyle interventions have benefits And there's now a whole new area of research exercise has really emerged As one of the areas that has grown With real biological evidence that it can prevent and improve brain function and brain health And beyond that if we see now people are looking at things like diet and supplements and other ways to manage those disease And so I think this is an area as just grant you know relatively new but very exciting Yeah, I mean there was a recent study called the finger study A finger study is one of the one which is fascinating Which I talked about in the book Yeah, I know and this study was done in Europe and it was a very large study where they did an intervention With diet and exercise and stress and And yes addressing cardiovascular risk factors and tell us about the study what are they fine? Yeah, so this study is done at the Carolenski Institute The the geriatrician her name is Mia Kivapelto Really really sharp very very thoughtful physician scientists And she said we're going to create a multimodal intervention including diet changes Managing health conditions improving Exercise improving all their parameters and one group was randomized to the intervention And one group was randomized to just kind of passive intervention And in an objective way followed for over two years With aggressive intervention the treated group did much much better over the two years Not only did they not get declined they actually got better Wow and so and these are people not young they were starting in their late 60s and their 70s So these aren't people in the middle of life. They're kind of in the senior they're running into the senior age And they actually got better and this has been published in the journal Lancet So it's a very respected you know peer-reviewed scientific journal Well, this is really remarkable. I just want to pause here because what you just said Is pretty radical now like I said we spent billions of dollars on hundreds of studies And none of them showed this we can't slow that's correct. It's great. Or reverse Now you're saying just by eating better exercising Optimizing your health We literally can slow and even start to reverse the disease. That's correct In fact the US as taking the finger study and in 2019 2020 there will be the US version of it called the pointer study Which will come which is being Rolled out in about six sites in the United States this year and the government has to pay for it because there's no drug in well The government well to be very close the pointer study so far as I know it's being funded by the Alzheimer's Association I don't know if there will be federal dollars behind it But the fundamental issue is not a drug company It is not a drug company But the fundamental issue is we want to answer an important question do these things objectively work the signal the way the evidence Suggest the answer is yes, and so having more evidence Because I have to tell you you and I are both physicians part of our day job is taking care of people with disease right So we're here. We are saying let's step back from that. Let's say instead of treating disease. Let's treat health. Yeah And did you do you take the course in medical school called creating health by one? I did not I did not take that course. Yeah, and we didn't know But you know, but the advantage of that is that it's not prescriptive then you can Health recommendations that come up from consensus panels and then it can have effect change at a larger level This is actually easier to roll out if we can prove there's a signal than it is by just writing a prescription It's unbelievable. Yeah, I think you know What you said is really remarkable that we need to focus on how do we create health rather than just treat disease or symptoms or pathways Or some pathology and that's essentially what functional medicine is it's asking the question How do you create a healthy human being what are the factors that knock you off that path and one of the things that actually Help create health and in those studies the finger study the point study are looking at those factors and there and there are more Right there are more and I think that's the exciting thing is that I think you know, I have to be tell you I've been involved in all these clinical trials Every time there's a failure it breaks everybody's heart. Yeah, it's there is no There is no ego involved. It's not like hi. I should told you so because I will say to you whether the drugs work or not I'm going to click tomorrow or the next day and I still got to look at these people in the eye and say you know something good is coming We just kind of hope that it's coming soon. Yeah And so I say this to you because If I can see a path forward whether it's a drug a device A lifestyle intervention any way forward to help my patients either prevent postpone or delay Hmm. Well, let's talk about the disease a little more in a medical way because The the understanding was from my training was that the brain seemed to be disconnected it from the rest of the body. We learned about this barrier called the blood brain barrier, where nothing except some nutrients got in. It was like this thing that can disconnect it our head from the rest of us. It turns out that our body is one system and then our brains are connected to everything else that's happening in our gut microbiome, infections, what we eat, everything is actually influencing our brain function. So can you share a little bit about how this understanding has changed the way we think about the brain and how some of these factors that are driving inflammation are actually causing this disease because it's a disease of brain inflammation. It is so the kind of the conventional wisdom that we're trying to look at is that inflammation is a response to an injury or is it the injury itself. At the end of the day, a lot of people think that there's an amyloid triggered event and then the inflammatory events occur because of the production of the amyloids. An amyloid is sticky, gooey stuff that comes up your brain. That is correct. And importantly, but we used to think, as you said, there was north of the neck and south of the neck. And that everything in the Alzheimer's was north of the neck and nothing south of the neck was related to it. When in fact, now we know that things like gut microbiome can alter your immune system and having a healthy microbiome can keep you healthy and the innate and you can boost your innate immunity which might reduce inflammation across the body, including the brain. Yeah, an exercise helps reduce inflammation and BDNF. So the exercise, I have to tell you, I hated running. But I've taken up running because of BDNF. So what is that? That's brain derived neurotrophic factor because it's like a miracle growth for the brain. It's a miracle growth for the brain and the funny part about it is almost neuroscientists are runners. They don't do anything but run. They have to have something to it. It's the fastest way to raise your BDNF. Which is basically this growth factor that connects your brain cells together. So it calls neuroplasticity which increases connections and helps neurogenesis which is the developing new brain cells. That is correct. So we never thought that was possible. You never thought it was possible. We said once you're born with the neurons, you're going to get it. But we now know that the brain's making neurons throughout their life. Yeah, I mean, I read a study where they studied terminal cancer patients and they gave them this die that only goes to dividing brain cells. And they found even at the point of death, they're making new brain cells. That's correct. When I was in Sun City, Arizona, at the Banner Sun Health Research Institute, we had a brain embodied donation program and we had scientists that could take brains of patients who just expired and culture out, bring out stem cells that were still left alive in dead brain. That's unbelievable. So cool stuff. So these things like diet and exercise and optimizing your gut microbiome and stress reduction, they all, in sense, work by regulating this inflammatory process. That is correct. That is correct. The inflammation, of course, is the unifying common pathway that we can manage. And you know, the end of the day, that's what we want to do. But study is good taking Advil. Never really worked. They tried it. Well, cox inhibitors have not worked. So then the questions are scientifically, is it that pathway of inflammation? People are now looking at different pathways of inflammation. Now we're looking at TNFL, which is Tune of course, is alpha. They're looking at the fact that TNFL, my trigger, enzymes related Alzheimer's called base. So we think that there's a links that inflammation is not just a broad category, but there's specific segments that seem to work and others that we've tried. Like you said, we try to anti-inflammatories for years to treat, to treat or prevent Alzheimer's, didn't work with the donor. Well, that sort of goes back to the thinking of functional medicine, which is what's causing it in the first place. So if you're standing on attack, it takes a lot of aspirin to make it feel better. Hold the tack out. So it's not, this is the best logic, but it's something that we have to sort of begin to wonder about. I talk into one of your colleagues, Rudy Tansy from Harvard, who said to me that they've done studies of patients who had brains full of this amyloid, but they had the gene somehow that didn't let them create inflammation and they were cognitively intact. They didn't have dementia. Right, and that's amazing things that you can go to your grave with a brain full of amyloid and not develop dementia. And we want to study those people because there's something's protecting them against the development of symptoms. And of course, they may have just less inflammation as you commented. Rudy Tansy would be the guy to figure that out. Yeah, and he talked about the microbiome of the brain. I don't think they're still trying to figure it out, but they're finding microbes in the brain. Right, we thought it was sterile up there, but turns out it may not be. It may not be. Right. There's a new one that you probably have just hearing about. There's a company out of the Bay Area that's found there's a oral bacteria called P-Gengevalis, which creates a protein called genjipane, which may be a neurotoxin and neurotrigger of neuroinflammation. And so they're looking at a drug to stop that. Maybe brushing your teeth, flossing, getting them clean is a good idea. Not just good for the heart. It's good for the brain. That's right. I mean, you probably know that, but one of the biggest triggers for heart disease is that's gum disease. That's correct. So let's talk about the genetics here for a minute. So, you know, most people think you get your genes, they're fixed, your your fate is sealed, there's nothing you can do. It's not actually how genes work. Now, you can modify these genes expression, which ones get turned on and off and how they work. And I remember, I had this patient years ago, who was a 90-year-old woman, she was a dentist. She had 8-po-e-double-four, meaning she had two of the worst genes you could have that our triggers are maybe predisposing to Alzheimer's. And she was 90 years old, she was still working, and she was completely cognitively intact, and she was a health not her whole life. She ate a perfect diet, she exercised, she never smoked, she never drank, she took her vitamin, I mean, it was remarkable to see that. Yeah. And this is what you talk about in this book with this woman, Jamie, she came to you because she had a family history of Alzheimer's. Yeah. And you checked her genes and she had that dreaded 8-po-e-4 gene, which many people are afraid to test because they feel like it's just a why why bother. And you you talk about why bothers. Right. So why bother? So, I'll answer the why bother in a second, but Jamie is like your dentist patient. She's a four dash four. She found her story, of course, she found out her genetic risk by accident. Now, you and I know that if you are two copies of the 8-po-e-4 gene, your lifetime risk is 91% that you're going to develop it. It's almost a matter of when, not if. Yeah. And the problems with is that fortunately, there's only 2% of the population that have our double copy, 20% of the population is a single copy of the 8-po-e-4, but people are now finding out because there's commercial genetic testing by accident. 23 and me. 23 and me, right? And then they go to Dr. Google, it's me and my friend Dr. Google. Yeah. And they're like, well, what does this mean? And they go on. And so the james of the world are finding out day in and day out by accident. And they're trying to figure out what does this all mean. So the story is on her half is how she found out by accident and how it affected her. My half of the book is is it a good idea to be tested? What are the consequences of being tested? What does it mean? And so that's what my half of the book is about. And it's a been, it's a nice convergence of two two storylines that help people to become informed because this is happening every day of the week. It's happening anyway, but what you're, your book fighting for my life suggests is that by knowing that, it can motivate people to take control of their life and their lifestyle and address the modifiable risk factors. That is exactly it. And I want everybody who reads the book to be like your dentist patient. Yeah. She was. I have to say to you, I had one other not sure about go to her nine years old. She got to nine. She was. Right. Yeah. And working. And working. And I've seen only one other elderly person get to late 80s, 90s, a four four who was unaffected. And my career, if I've almost said that if you have that genetic profile, it's almost a four gun conclusion to get Alzheimer's dementia eventually. But there was one exception of that. So we want everybody to be the exception. Yeah. The rule. Now, you know, one of the things we haven't really talked about yet is the role of sugar in the brain. Yes. And many people may remember Ronald Reagan's favorite food was jelly beans. Yes. And he got Alzheimer's now. Maybe there's a correlation. But it turns out the diabetics have four times the risk of getting dementia. That is great. And that we sometimes talk about Alzheimer's is type three diabetes. Yes. This Susan Delamante from University of Rhode Island. Yeah. Yeah. Brown. Yes. And the truth is that we all have control over whether or not we get diabetes. This is almost a hundred percent preventable and reversible disease by changing our diet. Right. And do you know that insulin resistance, of course, is the hallmark of type two diabetes. And that we can see insulin resistance in the brain. And that's what the type three diabetes, even if you're not having insulin resistance in the net rest your body. And we think that, of course, and I strongly believe it like you that that's a modifiable risk factor that we can alter that. We can alter it. Of course, the epigenome, which we're going to talk about. I hope we can double the genetics. But the diet and the reducing the sugar intake and the diabetes risk is something we can alter and have a positive effect on. So we all learned, I mean, I learned in medical school that your brain uses 25% of your glucose and it needs sugar to run. Yes, it does. And the PET scans show that you need sugar to make your brain light up. So the rule of thumb on a PET scan is you want your south of the neck, you want to be dark. North of the neck you want to be bright on sugar pet. Because if it's dark below, you got cancer. If it's bright below, you got cancer. If it's dark, that's why you're whether and the brain, you want it to be nice and bright. You want that brain to light up because it consume much of the sugar. sugar, couldn't metabolism is in the brain. But you also say in your book in patients who have Alzheimer's that people are exploring the role of ketogenic diets, which means no sugar. Correct. And lots of fat and the brain running on ketones instead of glucose. And the issue that people are trying to decide is can you bypass insulin pathway mechanism. So if you're relying on insulin and pathos related insulin to nourish your brain and you have insulin resistance, either you can pharmacologically improve that or you can dietarily improve that. I mean, you know, I remember this patient I had at the ultraviolinocenter, my practice on Linux and she came into about 78 and she started having what we call MCI or my cognitive impairment. And she had a whole bunch of things wrong with her. Fabulous, bad, she had gut issues, she had low vitamin B12, she had heavy metals and mercury. But she was able to fix a lot of these things and do a lot better for many years. And then she started to climb and I'm like, well, let's try a ketogenic diet. And we got someone to work with her and cook for her. And it was like the lights went on again. It was pretty dramatic. And I think there's some preliminary studies that are showing that. And you know, people have been looking at it. So the ketogenic diet all starts with the whole coconut oil conversation, which is coconut oil is controversial by itself. But the story behind ketogenic diets is that we do understand there's insulin resistance. And I actually funded a study looking at the ketogenic diets. So I think the science is there. It's just a matter of being able to prove it and more importantly to adhere to it. Ketogenic diets are not easy. It's not new to neurology. We've been using ketogenic diets to treat childhood epilepsy for 30 plus years. So it's not new to Alzheimer's but it's not new to brain disease. It's been used to treat other brain disease for a long, long time. And you know, fundamental is really hard to diet to stick to. Yeah. But we're finding more and more people are doing it. It's one of the hottest diet trends out there. If you look at all the best-selling books, it's not mine. It's the ketopugs. And we're seeing just much more interest. And we're running keto programs that include clinic. There are most popular programs, which is pretty amazing. So people seem to be willing to try it. I know you had Dan Perrmutter on a few weeks ago. And Dan and I have, of course, David Perrmutter. He and I have had an internet debate about this. I will say to you that I think it's more nuanced. I think that ketogenic diets that are insulin-sparing make more sense in the symptomatic phase of the disease. And I have to tell you, I look at Alzheimer's disease in a dichotomous way. There's the pre-symptomatic. And then there's the symptomatic. Symptomatic disease means mild-codermin perin dementia. And I think there is some logic to a ketogenic diet in the dementia phase. I agree. I think it's an ounce of prevention where the pound of cure is Benjamin Franklin. Correct. And I think that the ketogenic diet is the pound of cure. It's a pound of cure. But I would not necessarily advocate for it in the pre-symptomatic phase. I'm more advocating for the Mediterranean diet in the pre-symptomatic phase. And that's the beauty of your book. As you talk about how to create resilience and health. So you don't need the pound of cure. Correct. Because hope for life isn't to be restricted and restricted. It's to actually be more resilient, healthy, so you actually are resistant to these diseases. That's correct. So it's actually exactly the right idea. There are so many things that we can do to put the ball back in our court to write this script and tell our own story. Can you definitively 100% prevent Alzheimer's in every case? Well, no. I'm sure certain pretty rare genetic causes where basically just about anything you're going to do, you're going to get Alzheimer's and it's going to probably start early and that's unfortunate. But that is an exceptionally rare number of cases. Most cases of Alzheimer's you can do something about it. Based on this 2020 Lancet Commission, an amazing study. Based on 12 modifiable risk factors, we can, the person makes brain healthy choices prevent four out of every 10 cases of Alzheimer's disease. Wow. Like we didn't learn that in med school. Medical students now aren't learning that in medical school. It takes 10, 15, 20 years for something to be learned in medical science to be translated into clinical practice. And I think it's important for this podcast and people like us to share this news because there are so many things a person can do. So you ask me what can a person do? I want them to know there's so many things. At least 12. At least 12. So, you know, in our study, I think there's more, but there's at least 12. At least 12. In our study, we recommended on average 21 different things that a person can do and those were individualized per person. In our whole universe of our study, we recommended almost 50 things that a person can do. 50 things. Yeah. It was the brain that you identified. Yep. And it's, you know, this isn't radical. This isn't rocket science. This isn't like, you know, I'm a simple man. I did not graduate first in my med school class. I did pretty good and I worked pretty hard, but, you know, I just, I try to just see things from the patient's perspective. And there are so many things that are evidence based and safe. The two categories I would start with, just to kind of set the, set the stage are pharmacologic and non-pharmacologic. And I want to get it, get granular because the word pharmacologic doesn't just mean drugs and prescription drugs. It also means- Food is medicine. Well, food is definitely medicine. Yeah, they got sidetracked to non-pharmacological, but I can't see. I can't see. I can't see. I can't see. I mean, I can't see. Well, by the way, I'm sure we challenge you, Richard, because I think that food is actually real medicine. The phytochemicals, compounds in food are biological response modifiers, or single, transduction, trans-changers. And they have similar effects as drugs. In fact, many drugs come from the phytochemicals in plants. Right. So I would just kind of make a think about that a little bit. Well, actually, so I'm glad you brought that up. I would say that traditionally speaking, and let's talk through this. This is a great opportunity. So traditionally speaking, I've always framed it, and I'm open-minded. So this is great. And pharmacologically speaking, I'm just teasing. This is exactly why we're doing this. This is exactly a meeting of the mind. Let's go. Let's go. So drugs, vitamins, supplements, and medical foods are the classic things that I personally have categorized in the pharmacologic session. And then in the non-farm section, I've included diet, exercise, sleep, stress, a whole bunch of things, learning new things. But what you bring up is important. And you have a colleague named Dr. Robert Cricorian. And he's an amazing guy. He's a neuropsychologist, and he's fought the good fight, kind of like us. I don't want to say he's had-- and some ways that contrarian views, because he's tried to do randomized studies using nutrition. He's done studies on the ketogenic diet and Alzheimer's and Parkinson's. He's done studies on blueberries and omega-3s. And what he's done is he's taken the food. And he said, OK, it's not just about the blueberries. We did a study in wild blueberries or better. Well, why? Because of this thing. It's called anthrocyan. And then he gets down deep into it. So I completely agree that food is medicine, 100% agree. I completely agree that the specific chemical nutrient compounds can be isolated. But I think it's too reductionist to just say, let's just put a pill of amnesty. Anthrocyanins and prescribe that. Oh, that's right. Because it's the milieu. It's right. It's like with caffeinated coffee is good for brain health. Well, is it the caffeine? Is it the coffee? Well, no. They think it's like some substance ex during the brewing process. So depending on which way you look at the science, I would prefer that food is medicine. It's just sometimes-- I'm not worried. I understand the buckets. I'm just kind of playing with you. But I love it. I mean, when I put a patient, for example, on a ketogenic diet with Alzheimer's, and they wake up and their brain becomes alert, and they remember their son and their daughter. And I'm like, well, how is that less a drug than some other drug that doesn't work that we're using like arosypt, right? It's impressive. Yeah. No. I mean, I just feel like all of the different paths. Some people call nutrition, I don't know, not mainstream medicine. Like that, to me as a Western doctor, that doesn't make any sense to me. Nutrition is-- I got very little nutrition education in medical school, and I think that's a terrible thing. I learned a ton, and I had to-- my better half has a master's degree in nutrition from Columbia, and she's taught me a lot, I think, through osmosis. Wow, it's playing every time. There we go. It's always the better half, and she informs the lesson lightened one. So I guess what I'm trying to say is nutrition is the cornerstone of how we practice. Physical exercise and precision exercise, precision nutrition. These are all the things that are developing and really become the cornerstone of our care. You're talking about the 12, then the 21, and then the 50. Maybe there's going to be 100. Tell us more about the granularity on that. You were using these-- I just want to frame it for people. You did a study that you published in 2019, which surprised even you. We're using this approach looking at a personalized assessment of these biological factors that could be modified, and then individualizing the treatment. Let you not only slowed the decline. You not only stopped. the decline, but you reversed the decline, which is something that has never really been seen except in a couple of trials like the finger trial and I think there's anyone coming out the pointer trial. So those are those are also lifestyle trials. And so you really have sort of cracked the egg and published something that should have been on the front page of every major newspaper, the lead story and every evening news and yet it was like fricates. Yeah, well, I mean, I mean, we got the Wall Street Journal and CNN and this mother. So I'm okay, but I'm okay. But for me, it was like, it should have been like the NIH should have gone, oh, Richard, here's $10 billion to get going on. Like, that's what we should have. I have to be careful, but you know, the NIH doesn't really fund what we do. And that's been, it's very hard. And listen, the NIH, I've engaged with the NIH over the last year or two and there's definitely been more interest. But you know, I talk about crickets years ago, a decade ago when I started this whole thing, more 15 years ago, there was nothing. There was no there was no funding for any of this. So, you know, what I would say is, what are work shows is that when you individualize care and you give people a plan and I know you've asked me at least three times now, well, what should people do? What I'm trying, why am why I'm delaying things is because it really truly needs to be individualized and what we what we use is a term called the ABCs of Alzheimer's prevention management. Based on the data, we get data on A's, the B's and the C's, A stands for anthropometrics, anthropometrics is basically a fancy a word for body composition. What is your body fat? What is your waist circumference? What is your muscle mass? Depending on these factors, we're going to change the recommendations we give. The B stands for blood based biomarkers. We're going to look at markers of lipids, cholesterol markers, also advanced markers that preventative cardiologists use, for example, that most neurologists honestly don't really pay attention to. We look at metabolic markers, insulin resistance. We look at inflammatory markers. We look at nutrition markers. Instead of saying, okay, we'll go eat fish. It's good for you. We're going to look at the markers in the blood. We're then going to tell you based on your blood and based on your genetics, how much fish you should be eating, what types of fish. So, the take on point is we're going to get granular with every patient. The other thing we do is in the blood based biomarkers, we look at genetics. We look at the APOE4 variant. It's the most common risk. Jean doesn't mean you're going to get Alzheimer's if you have the variant, but it increases your risk. Well, if I know that you have the APOE4 variant, they check for this in 23 and me and millions of people have gotten this checked. I'm going to personalize your care differently. If you have the variant, I'm going to give you plan A, B and C. If you don't have the variant, I'm going to give you a little bit modified plan, X, Y and Z. If you have two copies of the variant, you have a different plan altogether. That's only one percent of the population. So, you know, the take home is we take all these markers and the C is cognitive function. And we understand a person's cognitive baseline. We look at memory function, language abilities, learning abilities, speed of processing, attention, and executive function, which is higher order processing. We take all of this and the patient's medical history. We learn about the patient. We learn everything we can about them, about their family, and then we personalize a plan. So, those 21 different things are based on that person individually. And you know, there's a lot of overlap. If you want me to say, "Okay, well, what are the core things?" Well, exercise on a regular basis. Okay, exercise on a regular basis is good, but every person gets a different plan. If we're putting someone on a plan for body fat loss, we're going to give them a different plan. We need to do a steady state cardio, for example, some people would call that zone two training. Steady state cardio at 60 to 65 percent of your heart rate. There's different ways to do this, to lactate testing, to a variety of things that we do, you know, more precisely in our clinic. But we put people on these steady state cardio plans, fasted in the morning as long as they can tolerate it because that way, it jumps start body fat loss. If we have people that don't do any muscle strength training because they don't like it, we educate them to say, "I don't like it either. I'm not. I'm not, you know what? Mr. Big Muscles over here, but I have to do strength training once or twice a week minimum because if you don't have muscles, you can't boost metabolism." So we put people on these very specific plans, high intensity interval training. I really believe that high intensity interval training is almost necessary for people with at least one copy of the APUE4 variant. And this is what has been studied down in a couple of studies. And yes, we need more research and the studies out of Norway were good, but we need to personalize an exercise plan. We need to personalize a nutrition plan. We need to personalize a vitamin and supplement plan. In some people, we do use drugs. You know, drugs are actually not commonly used at all in our research. Although we do use them on occasion, we'll use a variety of drugs, usually at much lower doses than maybe the regular community uses. But when it comes to management, I'm equal opportunity. If there's data and it's relatively safe, I'll entertain it. So we recommend cognitive activities that will have a spillover effect. Learning something new. Learning how to play a musical instrument. Learning a new language. These are things that may have a protective effect build backup pathways. Believe it or not, even learning how to play a musical instrument in mid life has protective effects on cognitive outcomes in late life. And that's for me. There's hope for you. I got my bass guitar over there. I got blisters in my hands. I know I'm playing a guitar. I'm trying, but I just love so. Well, my big problem is I don't know how to tune it. I am so musically in it that I probably there are good apps and things to do. There's a website. It's called, you got a pen. It's called YouTube. YouTube, you can infer to it. Almost as many people watch YouTube as listen to your podcast. So you can learn how to play guitar on YouTube. I think you can do it. Okay. I'm going to start. For sure. So that's my December. Excellent. And January and February and March. So the take on point is engage your brain. Treat your brain with respect. Love your brain. Make a plan for your brain. What does that mean? Make a plan for sleep. If you exercise and exercise and exercise, some people say colloquially that loosens the amyloid, the bad protein that gets build up in the brain of a person with Alzheimer's. But if you're burning the candle at both ends and you're not sleeping during sleep, especially deep sleep, that's when a person has the trash come. The trash man comes. They pick up the garbage and they take it out and they take it to the trash heap. That is the restorative part of sleep. And if someone isn't sleeping, at least 7, 7 and a half, 8 hours of sleep is usually the goal as we get older. It's part of the sleep that much. But making a plan for sleep. So we're prioritizing sleep. We have people that track their sleep, that track their exercise. I'm wearing a wrist device here. I have nothing to disclose. But we've done several research using this device. I track people on my phone. I have my phone right here and I can check how much exercise they've been doing, how they're sleep, how much deep sleep. I can see their blood sugar control. I can see all these different things on my phone because my patients share their data with me. When I talk about data sharing, it's not just about tracking sleep. It's not just about doing exercise. It's about tracking it, determining the response, talking to your physician about it, granted, it's hard to find physicians that will take the time to talk to you about this kind of stuff, tracking your blood sugar. There's, you know, at home devices called continuous glucose monitors. In our program, we take a very, very deep dive and we learn about all of these different metrics and we refine or fine tune the plan that we give them based on their real time measurements. So you know, I can keep going. There's stress modification. You know, transcendental meditation. Bob Ross taught me a ton about this. What about mindfulness-based stress reduction? You can take a course online. Mindfulness-based stress reduction has amazing outcomes when it comes to brain health. The list goes on and on. There's no one magic pill or one magic cure. But there are a variety of, huh, I was going to say pharmacological and non-pharmacological, but you're reevaluating how I say this now. There are a variety of interventions that are evidence-based and safe that I think all of us need to learn about. You know, whether we talk about fasting and I like the term time restricted eating better, meaning not eating for 12, 14, 16 hours overnight, at least four or five days a week. I use the term fasting for a more prolonged fast, you know, 24 hours or more and that's a different discussion. There's the ketogenic diet. There's a Mediterranean-style diet. There's a mind diet. There's components of each diet. Green leafy vegetables. Wild salmon. Grass-fed beef. Better than non-grass-fed beef because of the omega-3s. There's so many devilish in the details. Half a couple blueberries and strawberries, two to three times a week. You know, leads to better brain health outcomes and cognitive outcomes in the nurses' health study, you know, many years later on. There's dark cocoa powder. There's so many things that I can drop in as key things, but the take on point is all of these things need to be individualized. So let me ask you this because I mean, you know, for someone to just kind of feedback because what you're listening to, you're thinking, you're a neurologist, which also an immunologist, a cardiologist, an immunologist, a gastroenterologist, a nutritionist, right? You're breaking down the paradigm of medicine, which is we should stay in our lane, focus on our organ and leave the rest to everybody else. And your insight here is that the body is a system that everything's connected to everything. You can't just pick out one thing and work on that like ameloi or tau or whatever and get to the problem. And it's sort of like trying to you know, bail the boat while there's holes in it. You gotta fix the holes. And essentially the holes that you're talking about are all these ways in which our brain gets injured by our lifestyle and by our environment. And you didn't mention toxins, but that also plays a large role. And so all of a sudden we have to sort of rethink our whole approach, which has really been a reductionist approach. Single disease, single drug with a single outcome. There was an article in JAMA, number years ago called Shifting Thinking in Dementia. You probably saw it. And they said in that article that we combine categorical misclassification with etiologic in precision. In English, for those listening, that means we categorize dementia according to symptoms not the causes. And we are not very focused on the etiology or the causes. We're focused on the symptoms. And we said, well, you can't remember this and you fit this profile on your neurocognitive testing. You have Alzheimer's. You have this kind of dementia or Louis body or blah, blah, blah. And the reality is that you can have 10 people with Alzheimer's who need 10 different treatments. And that's exactly what you're talking about. That's heresy Richard. That's heresy in medicine. Honestly, because we really have a very, very restricted reductionist view of disease. It doesn't let us actually even study these things. And I literally had arguments with top leading researchers, like heads of research at major institutions saying, these are all the factors that affect the brain. We want to study them together. So, oh no, we have to study one thing at a time and then see how that works and then one thing. So study exercise and then study nutrition and then study vitamin D. Then study fish. And I'm like, no, that's not how things actually work. It's like you have to use all the whole picture. The other thing I sort of wanted to sort of touch on was that you're sort of introducing a concept of the personalization, which again is very different in medicine. It's not one size fits all. And you're talking about very sophisticated personalization based on a whole set of biomarkers and tests, things that are easily accessible. But that aren't normally looked at and that aren't normally tested. You know, you get your typical panel, you get your thyroid, you're B12, you get your spinal fluid done, you get your MRI and you go, okay, you got Alzheimer's. It's a little bit more complicated than that, but it's really a fairly narrow window of biomarkers and metrics. And there's bazillions of them. And I think we're just sort of touching the sort of tip of the iceberg on this. And I've seen in my patients when you start to apply these concepts of personalized care around food, around exercise, around sleep, around stress, around supplements, around everything that you really begin to see dramatic changes in brain function. Yeah, I often joke that I'm like a one-third neurologist, but a preventative neurologist at that. And I'm a third make-believe, I will full disclosure, I'm not a preventative cardiologist, but I may make believe preventative cardiologist. I'm a one-third primary care doctor and make-believe preventative endocrinologist. I don't even know any preventative endocrinologist. If you find one, introduce them to me. I was trained in an environment. I went to a six-year medical program where I was in med school from day one, University, Missouri, Kansas City. I knew I wanted to be a doctor when I was five. I was 18 years old, where are my white coat, and I did so much internal medicine during med school. I had like an extra year of medicine because that's the way our training was. I don't know if it was that or I'm not sure exactly what it was, but Alzheimer's disease is a medical disease. Yeah. Full stop. That's it. There's this thing called the skull and it's a hard thing that affects you when you fall. But it's just like when you have medical conditions, you can affect your kidneys. When you have medical conditions, it can affect your eyes, it can affect your heart. It's the same thing. It can affect your brain. I couldn't agree with you more. People can take different roads to Alzheimer's. You have to figure out what they're on and get them the heck off that road. Women, for example, are unfortunately many times in the fast lane to Alzheimer's. Women, two out of every three brains affected by Alzheimer's or women's brains. Five, ten years ago, I would say I didn't know why. Now I think I can answer that question. It's related to the paramedic post-transitions, related to specific life factors. It's related to women being maybe a little bit more at risk if they have the ape we for variant. The take on point here is if you understand a person's individual risk factors, whether it's biological sex, whether it's medical conditions, whether it's what's floating around in their blood, whether it's what is their cognitive function at baseline, you have to figure these things out and then you have to target that plan and personalize that plan. I mean, Alzheimer's disease and brain health needs to be treated in a medical way. Because if it's not, if you're just targeting amyloid, you're missing the boat. Amyloids are marker and I think hopefully one day we're going to have just like we treat diabetes with lifestyle interventions and exercise and as well as certain targeted drugs that honestly some of them actually do tend to work pretty well. I'm not the biggest fan of insulin like that. It's maybe bandating to me that's probably too late. I mean, I'm not the best. Whatever, but some of these new things that are pretty interesting, I won't get into specifics. But I hope that one day we treat Alzheimer's disease and cognitive decline like any other chronic disease of aging where we hit things with a multimodal evidence based and safe approach that requires a medical intervention. So essentially what you're saying to paraphrase is that Alzheimer's is not a brain disease. Correct. It's a systemic disease that affects the brain. Yeah, I really believe that. I have to be careful saying that is this being recorded? Yes. And it's going to be broadcast of billions of people around the world. Great. Great. I was just gaining some fans in my field and now it's all less decade of work. Oh, God. But you weren't the forefront of a paradigm shift. It's happening throughout medicine, which is the breakdown of the old concepts of disease from simply this reductionist organ based symptom based model to systems thinking and network medicine. And that's really all you're talking about. There's very strong compelling evidence at this point that bacteria are the cause of neurodegenerative diseases. Not my. Yeah, Rudy, we talked about Rudy Tanzi who's a Harvard scientist, one of the scuvers of some of the presinologen genes, which are the genes that show that people are risk for early Alzheimer's. He actually said they were discovering all these microbes in the brain, which we thought was sterile. And that we had this blood brain barrier that protects us. And you're saying, and he's saying that that barrier is not always 100%. And that stuff can leak through. Not only can you have a leaky gut, but you can have a leaky brain. Look, bacteria, not to scare people. Bacteria love the brain. Why? 25% of the body's glucose is used by the brain. They know where to eat. They go into lapen or the fancy restaurant is downtown. Like everyone else is eating downtown. They're getting our brains. They're coming back to you. Live on ketones. 100%. But not but not. That's very important. They prefer simple sugars. Why? Because they're lazy. They want instant gratification. So they like sugar better than ketones. But ketones and ketotic diets work for some of these neurodegenerative diseases like Alzheimer's. Even L.S. And the kind of cancer. That's right. That's right. And I think one of the mechanisms, to be honest with you, is that ketones actually improve, firstly they improve mitochondrial function, but they're not a good substrate for bacteria. They're a great substrate for us. Bacteria don't like them because they like eating fast food basically. Yeah. So, eat them sugar and we eat fat. That's right. Okay. So, this is just a breakthrough idea. And this isn't just an idea. You've actually treated patients using this approach. You've seen some really extraordinary things. Yes. So, can you share with us, you know, a little bit about this case you were sharing with me earlier about ALS, which is a horrible condition. It's even Hawking Hadad. It was called Lou Gehrig's disease after the baseball player. Essentially it's where your nervous system is affected by the killing of the neurons in your spinal cord, which makes you basically paralyzed. You got a fisculation, which is twitching. You eventually can move your arms and legs. You're in a wheelchair. You can't breathe. You need a respirator. You would wash it on your worst enemy. You would not wash it. It's like a slowly getting paralyzed. Right. That's right. And never has there been a treatment that has stopped or reversed it. Right. And you're saying that you've seen patients where this actually happened. So, well, we are in the process of validating that sort of that data. Yes. So, yes, we need more studies. Yes, we need to do research on multiple patients. Right. Even if there's one patient where you've seen a change, it raises the question. Oh, by the way, it's maybe go crazy, by the way, because, you know, I am so, I'm finally glad to be a neurologist. You know, being a neurologist is like being a nihilist or a masochist. Magnus Nadios, right? Well, it's worse than that. It's like diagnosed and let me, you know, let me not tell the patient that they have ALS. Let me treat them for, you know, like a CIDP picture because they don't want to actually make that diagnosis for people. It's the hardest diagnosis you can make for a patient. Right. knows ALS is incurable disease, right? I mean it's 100%. It's like not even pancreatic cancer is better. Well you have a 5% chance of living a pancreatic cancer. You have zero chance of living through this disease. Zero. So it makes sense that your hypothesis that it's infectious. Yes. That plays a big role if not is the main role. Right. You know, I personally shared on this podcast that I went to a place in Mexico called Xaniviv where I and my wife both went through this treatment called hypothermia, which essentially is where they heat you up to a hundred and seven degrees, which sounds crazy and is scary. Right. But actually we did both fine and it killed a lot of infections that we have. You mentioned it. Right. My wife, her viral loads of very tough to treat infection called CMV came plummeting down. She felt much better. I felt much better. And so this is a therapy that is not much used in the United States, but is used widely in Europe, is used in Mexico and other countries as a therapy for some of these types of infections that disease is and even cancer. Right. So how does the theory work behind this with something like ALS? Well, the idea is that fever is the way of actually denaturing spores. So that's a big sentence. Can you unpack that? They're proteins that either fold properly or not fold properly at a certain temperature. Bacteria have their own temperature zone like their ideal climate and spores have another ideal climate. Meaning that to kill a spore, a spore is like a baby bacteria. The spore is a baby bacteria. And that's what I believe personally is the reason that patients have amolate accumulation, that the spores are creating this protective cover against antibiotics that actually is, in fact, the amyloid being produced. So they amonize the armor for the bacteria? Yes. They're like the bomb shelter. The biofilm is the bomb shelter for these little baby bacteria. Yep. And so how does hypothermia work to disrupt that? Oh, so what is that? Because the procedure. Well, so it works, hypothermia works by, it's a very narrow window of temperature. Meaning if you give too much temperature, you can actually hurt normal cells as much as, you know, bacterial cells. If you don't give enough temperature, you've done nothing. So it's like Goldilocks. It's like Goldilocks. You got it. Just right. You have to get it exactly right. Okay. And that's part of the way that the hypothermia technology has been developed is by really understanding that the brain itself can provide feedback on the tolerability for human cells because brain cells are going to tell the brain, hey, this is pretty hot in here. You want to fry your brain. Right. Can you turn the thermostat off now? So the part of the device actually is to get the brain temperature back into the feedback system where it's self-regulating so that you never reach a point where the temperature is harmful to your own cells. And so, you know, often in places where they do this, they'll give at the peak of the temperature, they'll give antibiotics or antivirals. Right. Does that make sense? To give antivirals? Or, yeah, to give antimicrobial treatment to patients when they're at the peak of the fever because the idea is that it sort of flutters off the -- Yes, for acute infection, yes. I would argue that -- Why more? Well, if the line is acute, certainly. I mean, I don't think that -- I mean, I think you have to be weary of the issue that by, you know, you're robbing Peter to pay Paul, for instance. Let's say that C-diff is -- let's say -- let's say -- let's progress like I say, this is a polymicrobial disease, okay? As opposed to a -- Like lots of different books. Lots of different books. As opposed to just one ringleader that everyone else is following, okay? So, Lombard believes that C-diff is the ringleader, okay? And all these other guys, Lyme, HSV, they're just tagging around because it's such a great killer that it's like, okay, great. We'll take the leftovers. No problem here. So my concern is clinically that if we start treating patients, you know, with, you know, bacterial drugs like Rosef and whatever it is for chronic Lyme, yes, you're dressing chronic Lyme. I mean, it's -- He did catch worse. Yes. Exactly. So the heat alone is enough to disrupt the C-diff? It's -- well, we haven't demonstrated that yet to be quite frank, but what's been demonstrated is that by applying hypothermia that we're able to actually see improvement in clinical symptoms of patients with ALS. But people's muscle strength is a progressive disease. So it gets worse and worse and worse every visit they're worse. You're seeing patients that it stops or gets better, which never happened. Correct. This is a major breakthrough. I think so. Major breakthrough. And this is not -- I mean, new. This has been around for a long time. So where in the world is most of the research being done on hypothermia? For ALS? Period. I mean, it's -- Most -- so they're -- most of the research on hypothermia actually is cancer research. So they call it chemothermia, chemohypothermia. So people can look up a lot of data on how hypothermia affects cancer. But as far as I know, there's zero data until now applying hypothermia for ALS. We will be the first people to actually talk about applying hypothermia for treatment of ALS. One of the things like Alzheimer's or Parkinson's or MS? Well, the difference in those diseases are that in ALS, right, it's very difficult to induce hypothermia in the patient with ALS, why? Because you need to be compliant. The treatment itself is, you know, it's fairly rigorous as you know from your treatment. They put me in sleep. They put you in sleep, right? We don't want to put them in the sleep though, right? Because we're concerned about protecting their brain. So you know, you have a patient who's got, you know, end-staged Alzheimer's disease, for instance, I don't see how this is going to be held in them. But early -- But early 100 percent. Early. Early. In fact, I will talk later not about the case now because I -- we're really just in the beginnings of this case. But yeah, I think it's applicable for ALS as well. Have you seen any patients reported or in literally -- No. But you serve as a theory. Yes. It's still a theory. An MS? What about MS? MS, there's data on actually the opposite, right? Which is how do you induce hypothermia, right? Because an MS, it's a -- you know, it's an inflammatory disease obviously, right? Which by the way, I also believe is -- is caused by clastridium, but not -- not C-DIF, which is especially important to actually identify at that stage that this is bacterial. So there -- I don't know what -- Yeah. Yeah, so what -- what -- what is the idea with MS? You wouldn't want to use hypothermia, that you wouldn't want to use heat because it makes it worse? Well, because -- remember, when you heat up a patient with MS, what happens? They usually get worse. So the trick is -- But maybe not enough, right? Maybe it's not enough. That's right. Maybe you haven't reached the threshold to actually, you know, use the body's fever mechanisms against -- Because there's links to MS and Epsilibariris and other infections. There's links to Alzheimer's and Herpes virus infections. Right. Right. So, yes, the whole principle is applicable for those diseases. But we don't know yet if it is applicable yet until we clinically demonstrate that, right? But yeah, I think that this is going to be a treatment that's going to be very important for a lot of different diseases, Mark. So there's this whole theory that the body has a mechanism for dealing with this, and it has these own proteins that are produced in response to heat, and there are things we learned about in medical school. They're called heat shock proteins. And I learned something very important about heat shock proteins from Dr. Lessler, because remember that, you know, people looking at how to induce hypothermia, right? So there's also some research. It's actually even a drug in clinic for ALS that is -- the -- the -- the -- the -- the mechanism of action is based upon increasing heat shock protein through a pharmaceutical agent. So I was at this lecture, and I -- you know, I thought I knew everything, basically. And I learned that actually you could induce -- Did you thought MD stood for medical deity, is that it? Medical deity, yes, I was -- yes, exactly. We all got that training. Yeah. The truth is, we know close to nothing. That's why I said the beginning of the talk. I -- you know, like, I'm -- thanks for inviting me, but I really know nothing. Just disclaimer. But anyway, so, yes, actually, in MS, the goal is to induce heat shock protein through hypothermia. Yeah. Hypothermia. So you get people cold. Not people. The brain. The brain. Right. How do we do that? A chill, the brain. A chill, the brain. How do you do that? Ice blocks around the head? No. No. Well, I invite you up, and you could -- you could see for yourself what that looks like. All right. Done your head nice water? Nope. Nope. Nope. None of the above. Okay. So we have to be in mystery here. A mystery of what the device looks like? Yeah. It's basically the same concept as building a hyperthermia device, except -- remember now, the technology itself was developed basically for anesthesiologists. Those were developed at Yale by Dr. Abrayu, who's the person who actually discovered a way of measuring brain temperature objectively externally. Okay. So that's kind of where this whole thing started from, the Beyonce. And we don't just take electrode in your brain. You can really map it out from the outside. You can map it out from the outside. So the ability to do that now allows a clinician to not only, you know, heat the body to create hyperthermic. states, but through other types of modalities to actually cool the brain safely externally with the same, in the same way, meaning that you can actually apply a small device to a region of the skin, periorbital location, and you can actually change the temperature of the brain through this, what's called the brain thermal tunnel. And that also creates heat shock protein 70. And I didn't know that until I was in Australia. That's amazing. So you're hopeful about the future of neurology, sounds like. It's the first time I've been hopeful that anything in my life to be asked you. I hope you enjoyed today's episode. One of the best ways you can support this podcast is by leaving us a rating and review below. Until next time, thanks for tuning in. Hey everybody, it's Dr. Hyman. Thanks for tuning into the Dr. Pharmacy. I hope you're loving this podcast. It's one of my favorite things to do and introducing all the experts that I know and I love and that I've learned so much from. And I want to tell you about something else I'm doing, which is called Mark's Pix. It's my weekly newsletter. And in it, I share my favorite stuff from foods to supplements to gadgets to tools to enhance your health. It's all the cool stuff that I use. And then my team uses to optimize and enhance our health. And I'd love you to sign up for the weekly newsletter. I'll only send it to you once a week on Fridays. Nothing else I promise. And all you do is go to drhyman.com/pix to sign up. That's drhyman.com/pixpicks and sign up for the newsletter. And I'll share with you my favorite stuff that I use to enhance my health and get healthier and better and live younger longer. Just a reminder that this podcast is for educational purposes only. This podcast is not a substitute for professional care by a doctor or other qualified medical professional. This podcast is provided on the understanding that it does not constitute medical or other professional advice or services. If you're looking for help in your journey, seek out a qualified medical practitioner. If you're looking for a functional medicine practitioner, you can visit ifm.org and search their find a practitioner database. It's important that you have someone in your corner who's trained, who's a licensed healthcare practitioner, practitioner and can help you make changes especially when it comes to your health.

Podcast Summary

Key Points:

  1. Neurodegenerative diseases like Alzheimer's begin decades before symptoms appear, shifting focus to early risk identification and prevention.
  2. Lifestyle interventions, including diet, exercise, stress management, and gut health, can prevent, slow, and even reverse cognitive decline, as shown in studies like the FINGER trial.
  3. Chronic inflammation, influenced by factors like poor diet, inactivity, and oral health, is a key driver of brain disease, and reducing it is crucial.
  4. Genetics (like the APOE-4 gene) influence risk but do not determine fate; lifestyle choices can significantly modify genetic expression and outcomes.
  5. The brain is deeply connected to the body (e.g., gut microbiome, oral health), debunking the old idea of it being isolated by the blood-brain barrier.

Summary:

This transcription from "The Doctor's Pharmacy" podcast emphasizes that neurodegenerative diseases like Alzheimer's have a long pre-symptomatic phase, making early intervention critical. The discussion highlights that lifestyle factors are powerful tools for brain health. Research, such as the FINGER study, demonstrates that multimodal interventions involving diet, exercise, and managing health conditions can not only prevent cognitive decline but also reverse it in older adults.

A central theme is that chronic inflammation, fueled by poor diet, lack of exercise, and even gum disease, is a primary pathway for brain disease. While genetics like the APOE-4 gene increase risk, they are not deterministic; proactive lifestyle changes can alter genetic expression and outcomes. The conversation underscores a paradigm shift: the brain is intimately connected to overall bodily health, particularly through the gut microbiome and systemic inflammation, moving beyond the outdated view of it as an isolated organ.

The episode advocates for a functional medicine approach focused on creating health rather than just treating disease.

FAQs

The FINGER study was a large European trial that showed a multimodal intervention including diet, exercise, and managing health conditions could not only prevent cognitive decline but actually improve brain function in older adults over two years.

Exercise raises BDNF (brain-derived neurotrophic factor), which promotes neuroplasticity and neurogenesis, helping to form new brain cell connections and reduce inflammation.

Inflammation is a key driver of brain diseases like Alzheimer's, and factors such as diet, exercise, gut health, and stress management can help regulate this inflammatory process.

Yes, evidence from studies like FINGER indicates that lifestyle interventions, including diet and exercise, can slow and even reverse cognitive decline in some cases.

Having two copies of the APOE4 gene increases lifetime Alzheimer's risk to about 91%, but lifestyle factors can significantly modify this genetic risk.

The brain is influenced by the gut microbiome, infections, diet, and overall inflammation, showing that brain health is closely tied to systemic health.

Chat with AI

Loading...

Pro features

Go deeper with this episode

Unlock creator-grade tools that turn any transcript into show notes and subtitle files.